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The human genome contains an estimated 100,000 to 300,000 DNA variants that alter an amino acid in an encoded
protein. However, our ability to predict which of these variants are functionally significant is limited. We used a
bioinformatics approach to define the functional significance of genetic variation in the ABCA1 gene, a cholesterol
transporter crucial for the metabolism of high density lipoprotein cholesterol. To predict the functional consequence of
each coding single nucleotide polymorphism and mutation in this gene, we calculated a substitution position-specific
evolutionary conservation score for each variant, which considers site-specific variation among evolutionarily related
proteins. To test the bioinformatics predictions experimentally, we evaluated the biochemical consequence of these
sequence variants by examining the ability of cell lines stably transfected with the ABCA1 alleles to elicit cholesterol
efflux. Our bioinformatics approach correctly predicted the functional impact of greater than 94% of the naturally
occurring variants we assessed. The bioinformatics predictions were significantly correlated with the degree of
functional impairment of ABCA1 mutations (r
2¼0.62, p¼0.0008). These results have allowed us to define the impact of
genetic variation on ABCA1 function and to suggest that the in silico evolutionary approach we used may be a useful
tool in general for predicting the effects of DNA variation on gene function. In addition, our data suggest that
considering patterns of positive selection, along with patterns of negative selection such as evolutionary conservation,
may improve our ability to predict the functional effects of amino acid variation.
Citation: Brunham LR, Singaraja RR, Pape TD, Kejariwal A, Thomas PD, et al. (2005) Accurate prediction of the functional significance of single nucleotide polymorphisms and
mutations in the ABCA1 gene. PLoS Genet 1(6): e83.
Introduction
The ATP-binding cassette transporter A1 (ABCA1) is a
cholesterol and phospholipid transporter, and mutations in
ABCA1 cause Tangier disease (TD) [1–3], a rare disorder
characterized by reduced levels of plasma high density
lipoprotein (HDL) cholesterol and increased risk for coro-
nary artery disease [4]. More than 70 coding variants have
been reported in the ABCA1 gene, including 30 missense
mutations, ten coding single nucleotide polymorphisms
(cSNPs), and many large and small deletions and insertions
[5]. Variants detected in individuals with TD have been
assumed to impair the function of ABCA1. However, without
functional testing of individual variants, it has not been
possible to determine which of these variants directly affect
ABCA1 protein function. This is a fundamental problem in
human genetics, in which most DNA variants are not
functionally tested and the number of individuals with any
given mutation is often small, making statistical assessment
difﬁcult or impossible.
We used an evolutionary model to predict the functional
consequence of genetic variation in the ABCA1 gene and
tested these predictions through in vitro assessments of
protein function. We predicted the functional consequence
of each variant in ABCA1 using PANTHER [6], a collection of
protein families and subfamilies that allows one to ask the
question, how often does a given amino acid occur at a given
position in a family of evolutionarily related proteins across
different species? PANTHER uses as its dataset the natural
experiment of evolution, in which over time, random
mutation will test every amino acid–coding nucleotide
sequence in the genome, with those variants that do not
impair protein function being represented in the dataset of
extant proteins. The probability that a given coding variant
will cause a deleterious functional change is estimated by the
substitution position-speciﬁc evolutionary conservation (sub-
PSEC) score, derived from the probabilities of observing the
variant amino acids in a PANTHER hidden Markov model
(HMM).
PANTHER subPSEC scores have previously been shown to
statistically distinguish Mendelian disease-associated missense
mutations from random coding polymorphisms on a genomic
scale [7]. Here we test the hypothesis that subPSEC scores can
predict which speciﬁc variants in ABCA1 will be functionally
impaired, and to what degree.
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Prediction of Functional Effect of ABCA1 Mutations and
cSNPs
We used data from the PANTHER database to predict the
functional signiﬁcance of each of the 30 missense mutations
and ten cSNPs reported in the ABCA1 gene [5]. The output of
PANTHER, the subPSEC score, is the negative logarithm of
the probability ratio of the wild-type and mutant amino acids
at a particular position. PANTHER subPSEC scores are
continuous values from 0 (neutral) to about  10 (most likely
to be deleterious). The subPSEC scores for ABCA1 mutations
and cSNPs are shown in Table 1. Twenty-three of the 30
ABCA1 mutations score below  3, the previously identiﬁed
cutoff point for functional signiﬁcance [6], compared to two
of ten cSNPs (p ¼ 0.002, Fisher’s exact test). The mean
subPSEC score for ABCA1 mutations is  4.82 compared to
 2.03 for SNPs. Figure 1 shows the distribution of subPSEC
scores for ABCA1 mutations and cSNPs. Compared to the
dataset of ABCA1 cSNPs, ABCA1 mutations have signiﬁcantly
lower subPSEC scores (p , 0.0001, Mann-Whitney U test).
Therefore, the majority of ABCA1 mutations are predicted to
impair the function of the ABCA1 protein on the basis of the
variability of the particular amino acid positions at which the
variants occur in evolutionarily related proteins, compared to
only a small fraction of cSNPs.
Functional Assessment of ABCA1 Variants
In order to test experimentally the bioinformatics pre-
dictions, we established stably transfected polyclonal cell lines
with which to assess cholesterol efﬂux as a measure of ABCA1
function. We established cell lines for 18 of the ABCA1 alleles
for which we predicted modulation of ABCA1 function using
PANTHER, representing 13 mutations, four cSNPs, and wild-
type ABCA1 as a control. We choose at least one SNP and one
mutation from each of the predictive categories, neutral and
deleterious. In addition, we attempted to choose variants for
which substantial clinical data are available in order to
correlate our ﬁndings with patient phenotypes.
All ABCA1 alleles expressed protein (R. Singaraja, H.
Visscher, E. R. James, G. Chimini, and M. R. Hayden,
unpublished data), with the exception of the S1731C cell
line, for which we observed low levels of protein expression
from two independently generated cell lines. To conﬁrm that
the S1731C allele was being expressed, we performed RT-PCR
for ABCA1 on reverse-transcribed RNA from untransfected
293 cells and cells transfected with the wild-type or S1731C
ABCA1 alleles. We found that cells transfected with the
S1731C allele expressed abundant ABCA1 mRNA, at levels
comparable to that of wild-type ABCA1 (Figure S1). The
S1731C allele therefore expresses normal ABCA1 mRNA but
fails to generate signiﬁcant amounts of ABCA1 protein.
We next evaluated the biochemical deﬁcit resulting from
each sequence variant by assessing apolipoprotein A-I (apoA-
I)–dependent cholesterol efﬂux in these cell lines. Cholesterol
efﬂux values from cell lines expressing the ABCA1 alleles are
shown in Table 2. Of the ﬁve variants we tested that were
predicted to be functionally neutral (subPSEC .  3), R219K,
V771M, I883M, D1289N, and P2150L, four had cholesterol
efﬂux values that were not statistically different from wild-
type ABCA1. This included two variants, D1289N and P2150L,
that have been previously reported to be disease-causing
mutations [4,8,9], as well as two cSNPs, R219K and V771M.
One variant, I883M, was predicted to be functionally neutral
but found to have cholesterol efﬂux modestly but signiﬁcantly
reduced (approximately 70% of wild-type ABCA1, p , 0.01).
This SNP has been reported to be associated with decreased
HDL cholesterol and increased severity of atherosclerosis in
Table 1. subPSEC Scores and Probability of Functional Impair-
ment (Pdeleterious) for ABCA1 Mutations and SNPs
Mutations SNPs
Variant SubPSEC Pdeleterious Variant subPSEC Pdeleterious
P85L  4.62 0.83 R219K  0.57 0.08
H160F  2.79 0.45 V399A  2.26 0.32
R230C  4.27 0.78 V771M  2.86 0.46
A255T  1.81 0.23 T774P  1.99 0.27
E284K  2.34 0.34 K776N  3.53 0.63
Y482C  4.21 0.77 V825I  1.06 0.13
R587W  6.04 0.95 I883M  1.38 0.17
W590S  5.19 0.9 E1172D  1.96 0.26
W590L  4.48 0.82 R1587K  0.58 0.08
Q597R  7.15 0.98 S1731C  4.21 0.77
T929I  4.29 0.78
N935H  8.54 1
N935S  7.53 0.99
A937V  6.6 0.97
A1046D  7.52 0.99
M1091T  3.56 0.64
D1099Y  6.09 0.96
D1289N  2.48 0.37
L1379F  3.81 0.69
C1477R  5.44 0.92
S1506L  5.17 0.9
N1611D  5.69 0.94
R1680W  6.02 0.95
V1704D  3.21 0.55
N1800H  4.23 0.77
R1901S  5.06 0.89
F2009S  2.73 0.43
R2081W  8.08 0.99
P2150L  2.88 0.47
Q2196H  2.74 0.43
DOI: 10.1371/journal.pgen.0010083.t001
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Synopsis
A major goal of human genetics research is to understand how
genetic variation leads to differences in the function of genes.
Genome sequencing projects have generated large amounts of
sequence data, yet our ability to predict which specific sequence
variants will result in functional differences is currently limited. To
address this problem, the authors use an evolutionary model to
predict the functional significance of genetic variation in the ABCA1
gene. To predict the functional impact of genetic variation in this
gene, the authors compare the specific sites at which the variants
occurred in evolutionarily related proteins and generated a like-
lihood score of functional impairment. These predictions were then
compared to actual functional measurements of each variant. The
authors show that it is possible to accurately predict which specific
variants will affect ABCA1 function and to what extent. These results
suggest that the evolutionary approach used may be a useful
method in general for determining the functional consequence of
genetic variation, which should aid in the study of how genetic
variation contributes to phenotypic differences.some [10,11], but not all [12], association studies, supporting
the concept that this is a functional variant.
We generated stably transfected cell lines expressing 12
different ABCA1 variants that were predicted to impair
ABCA1 function. All 12 of these variants had cholesterol
efﬂux levels that were signiﬁcantly reduced compared to
wild-type ABCA1 (Table 2), indicating that PANTHER
correctly predicted the functional impact of each of these
variants. The ABCA1 cSNP, S1731C, has a subPSEC score of
less than  3, predictive of a deleterious effect on ABCA1
function. Cells transfected with the S1731C allele displayed a
signiﬁcant reduction in cholesterol efﬂux, relative to wild-
type ABCA1 (p , 0.01), indicating that this SNP signiﬁcantly
impairs ABCA1 function, as predicted by PANTHER. These
data indicate that S1731C may be a useful SNP to use as a
functional marker in association studies.
Of all ABCA1 alleles tested functionally, M1091T displays
the greatest reduction in cholesterol efﬂux (6.9 6 20% of
wild-type ABCA1), consistent with previous reports that this is
a severe mutation associated with a severe clinical presenta-
tion [4,13]. However, the PANTHER score for this mutation
( 3.56) is only marginally predictive of a negative impact on
function, because while this position is conserved in ABCA1
proteins in other species, it is less conserved among other
members of the human ABCA subfamily of proteins, the
orthologous position aligning a leucine in the closely
paralogous ABCA7 protein (Figure 2A). To determine
whether the severe phenotype conferred by the M1091T
mutation is a result of the sensitivity of this site, or rather is
speciﬁc to the insertion of the threonine residue, we
generated and characterized cell lines transfected with
plasmids bearing M1091L and M1091V alleles, both predicted
to have no impact on ABCA1 function (subPSEC scores 2.65
and  2.71, respectively). Interestingly, both of these muta-
tions dramatically impair cholesterol efﬂux, to a similar
extent as the M1091T mutation (Figure 2B). Therefore, amino
acid position 1091, occurring in the ﬁrst nucleotide binding
domain of ABCA1 [5], appears to be exquisitely sensitive to
mutation and absolutely critical for ABCA1 function, despite
its relatively modest conservation in related human ABCA
proteins. This ﬁnding also supports the notion that any
amino acid changes in the nucleotide binding region of
ABCA1 are likely to have signiﬁcant functional effects
regardless of their evolutionary conservation.
Data from PANTHER can also be used to calculate the
probability that a given variant will have a deleterious effect
on protein function (Pdeleterious), such that a subPSEC score of
 3 corresponds to a Pdeleterious of 0.5 (see Materials and
Methods for details). Figure 3 shows a plot of cholesterol
efﬂux of individual ABCA1 variants versus the probability of
each variant being functionally impaired. The Pdeleterious
value is signiﬁcantly correlated with cholesterol efﬂux for
ABCA1 mutations (r
2 ¼ 0.62, p ¼ 0.0008), indicating not only
that PANTHER can discriminate between neutral and func-
tional mutants but also that those variants with a greater
Pdeleterious tend to have more severe impairments in function.
Inclusion of ABCA1 SNPs in the linear regression also reveals
a signiﬁcant correlation (r
2 ¼ .56, p ¼ 0.0004), indicating that
this relationship is signiﬁcant across all ABCA1 variants.
Assessment of Rare ABCA1 Variants Identified in the
General Population
Recently, Cohen et al. [14] reported that a signiﬁcant
proportion (;16%) of individuals with low HDL cholesterol
Figure 1. Comparison of subPSEC Scores for ABCA1 cSNPs, Mutations,
Recently Described Variants in a Cohort of Individuals with Low HDL
Cholesterol from the General Population [14], and a Random Distribution
of Low Frequency Alleles
ABCA1 cSNPs (open circles) have significantly greater subPSEC scores
than do mutations (filled squares) (p , 0.0001, Mann-Whitney U test).
subPSEC scores for ABCA1 variants described in the general population
(filled triangles) are significantly different from those of both ABCA1
cSNPs and mutations (p , 0.01, Mann-Whitney U test), as well as from
the random distribution of ABCA1 variants (p , 0.001), indicating that
this group of variants consists of both functional and neutral variants.
DOI: 10.1371/journal.pgen.0010083.g001
Table 2. Cholesterol Efflux Values for 293 Cells Transfected with
ABCA1 Variants and subPSEC and PolyPhen Predictions of the
Functional Impact of these Variants
Variant Variant Type subPSEC Cholesterol Efflux PolyPhen
R2081W Mutation  8.08 21.1 6 21%* Probably damaging
N935S Mutation  7.53 29.3 6 13%* Benign
A1046D Mutation  7.52 16.8 6 7%* Possibly damaging
Q597R Mutation  7.15 17.7 6 14%* Probably damaging
R587W Mutation  6.04 31.7 6 33%* Probably damaging
C1477R Mutation  5.44 20.5 6 10%* Probably damaging
W590S Mutation  5.19 47.1 6 13%* Probably damaging
S1506L Mutation  5.17 17.8 6 15%* Probably damaging
T929I Mutation  4.29 69.9 6 11%* Possibly damaging
N1800H Mutation  4.23 31.3 6 16%* Possibly damaging
S1731C SNP  4.21 12.3 6 10%* Possibly damaging
M1091T Mutation  3.56 6.9 6 20%* Probably damaging
P2150L Mutation  2.88 88.4 6 21% Probably damaging
V771M SNP  2.86 145.4 6 33% Benign
D1289N Mutation  2.48 137.7 6 86% Benign
I883M SNP  1.38 69.1 6 16%* Benign
R219K SNP  0.57 103.7 6 21.05 Benign
Wild-type — 0.0 100% —
*p , 0.01 compared to wild-type ABCA1.
DOI: 10.1371/journal.pgen.0010083.t002
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Accurate Prediction of ABCA1 Variantsfrom the general population have rare sequence variants in
ABCA1. An important unanswered question from these data is
what functional deﬁcit results from these rare ABCA1 alleles.
We used data from PANTHER to predict the functional
consequence of each of the 24 ABCA1 alleles found in
individuals with low HDL cholesterol by Cohen et al. (Table
3). This set of variants is shifted toward lower scores compared
to the set of common ABCA1 cSNPs (p , 0.01, Mann-Whitney
U test) (Figure 1). The subPSEC scores for the Cohen et al. set
of variants are also signiﬁcantly greater than those observed
for ABCA1 mutations (p , 0.01, Mann-Whitney U test),
indicating that this set of alleles is signiﬁcantly different from
both ABCA1 mutations and SNPs. Fourteen of these 24 alleles
(58%) have subPSEC scores less than 3, compared to 77% of
ABCA1 mutations and 20% of ABCA1 cSNPs.
In order to control for the possible confounding effect of
comparing subPSEC scores of variants with very different
frequencies, we compared the distribution of subPSEC scores
for the Cohen et al. variants to the distribution of random
single-nucleotide missense changes in ABCA1. Recent low-
frequency mutations that have not yet been subject to
signiﬁcant selection pressures would be expected to approx-
imate such a random model. To estimate the resulting
distribution of subPSEC scores, we calculated the scores for
all single-nucleotide missense variants in ABCA1, weighting
the contribution of each variant by transition/transversion
Figure 2. Conservation of ABCA1 Amino Acid Position 1091 in Related Proteins and Functional Effect of Mutation at This Site
(A) Multiple sequence alignment adapted from the view of family PTHR19229 available on the PANTHER Web site, showing the ABCA1, ABCA2, ABCA4,
and ABCA7 subfamilies. Human ABCA1 position 1091 is highlighted in red; other conserved positions are highlighted in blue.
(B) Cholesterol efflux was assessed in 293 cells stably transfected with wild-type, M1091T, M1091L, or M1091V ABCA1 alleles. *p , 0.001.
DOI: 10.1371/journal.pgen.0010083.g002
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Accurate Prediction of ABCA1 Variantsratios. Figure 2 shows that the distribution of subPSEC scores
for Cohen et al. variants is shifted signiﬁcantly toward lower
scores than the random distribution (p , 0.001, Mann-
Whitney U test). The Cohen et al. set of variants is therefore
predicted to be enriched in deleterious alleles but likely to
also include neutral variants.
Comparison with PolyPhen
PolyPhen (Polymorphism Phenotyping; http://genetics.bwh.
harvard.edu/pph) is a Web-based program used to predict
allele function based on homology and three-dimensional
structural models where available [15], and it predicts alleles
as being ‘‘probably damaging,’’ ‘‘possibly damaging,’’ or
‘‘benign.’’ In the dataset of variants for which we assessed
cholesterol efﬂux, the predictions made by PANTHER and
PolyPhen were signiﬁcantly different for two mutations:
N935S and P2150L. PolyPhen predicted N935S to be benign,
while PANTHER predicted it to be deleterious. Conversely,
PolyPhen predicted P2150L to be probably damaging, while
PANTHER predicted it to be neutral. In both of these cases,
the PANTHER predictions were correct. Using the set of 12
ABCA1 variants described by Cohen et al. [14] for which
macrophage efﬂux is reported as a second dataset, the
PANTHER prediction differs signiﬁcantly from PolyPhen in
one case, where PANTHER correctly predicts that L1026P
will be deleterious (efﬂux rates  2 SDs below control levels),
while PolyPhen predicts the substitution will be benign.
Therefore, while PANTHER predictions correlate quite
closely with those of PolyPhen overall, the PANTHER
predictions are correct in the three instances in which they
differ signiﬁcantly, representing a signiﬁcant difference in
the ability of these two approaches to correctly identify
functionally signiﬁcant alleles (p , 0.05, Fisher’s exact test).
Discussion
By combining bioinformatics predictions with direct
biochemical assessment, we have shown that it is possible to
accurately predict the functional consequence of amino acid
variation on protein function using an evolutionary model.
We demonstrated that it is possible to differentiate cSNPs
from mutations in ABCA1 using data from PANTHER (Figure
1), indicating that ABCA1 mutations tend to occur at much
more highly conserved positions in evolutionarily related
proteins compared to cSNPs. This ﬁnding within a single
gene is in agreement with the genomewide ﬁnding that
mutations from the Human Gene Mutation Database have
lower subPSEC scores than the randomly collected SNPs from
the dbSNP database [6].
We used an in vitro test of ABCA1 function in stably
transfected polyclonal cell lines to determine the biochemical
impact of the ABCA1 sequence variants and to evaluate the
predictions made by PANTHER. Overall, PANTHER cor-
rectly predicted the functional impact of greater than 94%
(16 of 17) of the naturally occurring sequence variants that we
examined. The subPSEC score cutoff of  3 suggested in the
initial characterization of subPSEC scores [6] worked well for
predicting functional variants in ABCA1, and no other cutoff
would have improved the prediction accuracy. In addition,
cholesterol efﬂux was signiﬁcantly correlated with the
probability of a deleterious effect for ABCA1 mutations, as
well as across all variants, indicating that PANTHER scores
are a signiﬁcant and reliable predictor of the degree of
functional impact of ABCA1 amino acid variants.
Both the D1289N and P2150L mutations are reported as
pathogenic and causative of disease in the TD patients in
which they were identiﬁed [4,8,9]. However, we predicted that
Figure 3. Correlation of Cholesterol Efflux Values with the Probability of
a Functional Impairment (Pdeleterious) for ABCA1 Mutations (filled squares)
and SNPs (open circles)
PANTHER predictions are significantly correlated with the severity of
impairment of ABCA1 mutations (r
2 ¼ 0.62, p ¼ 0.0008) and of all ABCA1
variants (r
2 ¼ 0.56, p ¼0.0004). The linear regression shown is for ABCA1
mutations.
DOI: 10.1371/journal.pgen.0010083.g003
Table 3. subPSEC Scores for ABCA1 Variants Described in a
Cohort of Individuals with Low HDL Cholesterol from the
General Population
Variant subPSEC Score Macrophage Efflux PolyPhen
D1706N  6.57 0.38
a Possibly damaging
C1477F  5.55 0.34
a Probably damaging
W590S  5.19 — Probably damaging
H551D  4.99 0.32
a Probably damaging
P85L  4.62 0.8 Probably damaging
W590L  4.48 0.31
a Probably damaging
N1800H  4.23 0.27
a Possibly damaging
R965C  4.22 0.59 Probably damaging
S1731C  4.21 0.28
a Possibly damaging
A1670T  4.2 — Possibly damaging
K401Q  4.2 — Benign
T459P  4.11 0.28
a Possibly damaging
R638Q  4.08 — Possibly damaging
L1026P  3.86 0.25
a Benign
T2073A  3.84 0.28
a Possibly damaging
E815G  3.53 — Probably damaging
R1615Q  3.45 — Possibly damaging
S1181F  3.44 — Possibly damaging
R306H  3.31 — Benign
E1386Q  2.44 0.51 Benign
S1376G  2.19 — Benign
R1341T  2.09 — Possibly damaging
D2243E  1.6 — Benign
P248A  0.18 — Benign
aEfflux value is 2 SDs or more below control levels of 0.52 6 0.07.
Macrophage efflux is as reported by Cohen et al. [14].
DOI: 10.1371/journal.pgen.0010083.t003
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Accurate Prediction of ABCA1 Variantsthese variants would not impair ABCA1 function based on
the variability of the sites at which they occur in evolutio-
narily related proteins. We were able to conﬁrm this
prediction in vitro, indicating that these mutations are
benign sequence variants and are unlikely to be causal of
disease. The TD patient described with the D1289N variant
was also homozygous for a second mutation, R2081W [9], and
our results strongly suggest that it is this second mutation,
and not D1289N, that causes the phenotype observed in that
patient. The molecular cause of the phenotype in patients
carrying the P2150L variant remains to be determined, and it
is possible that these patients harbor a second, yet unidenti-
ﬁed coding or noncoding variant.
The amino acids at positions 1289 and 2150 are conserved
among all ABCA1 orthologs we examined but not among the
closely paralogous ABCA7 and ABCA4 subfamilies. Because
conservation patterns in ABCA1 proteins have persisted for
only a relatively short time in evolutionary history, it is
difﬁcult to determine if the conservation at a given position
among ABCA1 orthologs is due to functional constraint or
simply reﬂects random chance. Accordingly, the amino acid
probability proﬁles for these positions are determined only
from ABCA1 orthologs (see Materials and Methods), which do
not contain enough sequence variability to conclusively
assume functional constraint. Our efﬂux data showing that
the D1289N and P2150L mutations are functionally neutral
conﬁrm the prediction that the conservation of these
residues among ABCA1 proteins is not due to functional
constraint, but rather reﬂects their recent common ancestry.
One ABCA1 cSNP, S1731C, had a subPSEC score less than
 3. Interestingly, this SNP has been described in a French-
Canadian family that also carries the 2144X stop mutation on
a separate ABCA1 allele [10]. Individuals carrying both the
2144X mutation and S1731C had signiﬁcantly lower HDL
cholesterol than individuals with only the 2144X mutation,
although the number of patients in each group was small [10].
Cells transfected with the S1731C allele expressed ABCA1
mRNA at levels comparable to wild-type ABCA1; however, this
cell line expressed low levels of ABCA1 protein and was
markedly deﬁcient in cholesterol efﬂux. Substitution of
cysteine for serine at this residue therefore signiﬁcantly
impairs ABCA1 function, as predicted by PANTHER analysis,
by interfering with protein expression. The mechanism by
which this SNP inhibits protein expression remains to be
determined but may involve expression of an unstable
protein that is rapidly degraded, or interference with protein
translation. The identiﬁcation of S1731C as a functionally
signiﬁcant variant indicates that it may be a useful DNA
marker to be used in association studies. These results also
demonstrate that PANTHER may be a useful tool in general
to identify functional SNPs that would be most useful for
studying in association studies.
Recently, it was reported that rare amino acid variants in
ABCA1 occur in a signiﬁcant percentage of individuals from
the general population with low HDL cholesterol [14]. We
predicted the functional consequence of these 24 ABCA1
sequence variants using PANTHER. The subPSEC scores of
this group of variants are intermediate between and
signiﬁcantly different from those of both ABCA1 mutations
and SNPs. We show that the subPSEC score distribution for
these variants is not due to random rare variants, which is
consistent with the conclusion that these variants are not
simply randomly sampled but are biased toward deleterious
functional effects. Our data are therefore in agreement with
Cohen et al. in that many (;58%) of these variants are
predicted to impair ABCA1 function and could therefore
underlie the low HDL phenotype in these patients. However,
subPSEC scores for these variants are also signiﬁcantly
greater than the subPSEC scores for mutations involved in
the Mendelian disorder TD. This suggests that a substantial
proportion of these variants may not impair ABCA1
function, and therefore suggest that other genes, or other
undetected ABCA1 variants, could be responsible for the low
HDL phenotype in these individuals. Consistent with this
hypothesis, approximately 33% of the variants functionally
tested by Cohen et al. [14] were not functionally impaired.
It is equally informative to consider the incorrect
predictions made by our evolutionary conservation-based
method, in order to understand the limitations of this
method and to suggest how it might be improved. The
incorrect predictions occurred at two positions in ABCA1,
883 and 1091. The subPSEC score for the naturally occurring
M1091T mutation ( 3.56) is only marginally predictive of a
negative impact on function, but this variant resulted in a
severe reduction in ABCA1 function, consistent with the
severe phenotype observed in patients harboring this
mutation [4,13]. In addition, both the M1091V and M1091L
substitutions severely impaired the function of ABCA1, yet
they were predicted to be functionally neutral. Among closely
related ABCA1 homologs, ABCA2 and ABCA4 both share a
methionine at this position, while ABCA7 substitutes a
leucine. From the evolutionary tree, it is apparent that the
ancestral amino acid at this position is likely to have been
methionine, with ABCA7 diverging from the ancestral
sequence (Figure 2A). Therefore, when calculating amino
acid probabilities for position 1091, the subPSEC method
includes sequences from only ABCA1 and ABCA4, which
represents enough sequence variability to predict that a
relatively radical mutation such as M1091T will likely be
deleterious but not enough to predict that relatively
conservative mutations such as M1091L or M1091V will be
deleterious. Our experimental ﬁnding that M1091L severely
impairs ABCA1 cholesterol efﬂux suggests that substitution
of leucine for methionine at this position may have played an
important role in the functional divergence of ABCA7 from
ABCA1. Consistent with this hypothesis, ABCA1 and ABCA7
have recently been demonstrated to be functionally diver-
gent, with ABCA7 facilitating the efﬂux of phospholipids but
not cholesterol [16]. In addition, the two proteins mediate the
formation of distinct HDL particle subpopulations [17].
Taken together, our efﬂux data and the functional divergence
of ABCA1 and ABCA7 suggest that human ABCA1 position
1091 is a critical functional site despite the relatively modest
conservation at this position.
The I883M substitution results in a milder phenotype, with
a modest but signiﬁcant reduction in ABCA1-mediated
cholesterol efﬂux. This variant is interesting, as both alleles
are found in the human population and the minor allele,
methionine, is likely to be the ancestral allele at this position
(Figure 4). Among the human ABCA1 orthologs, murine
ABCA1 aligns valine at this position and the chimpanzee
sequence aligns methionine. This divergence explains why a
simple conservation-based approach predicts that I883M is a
neutral substitution. However, ABCA1 has recently been
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positive selection since the divergence of humans with
chimpanzees [18]. Ourexperimental resultsshowing increased
efﬂux activity of the I883 versus M883 allele suggest that the
M883!I883 mutation may have been one of the adaptive
changes in ABCA1 that occurred during the evolution of
modern humans. This also suggests that measures of positive
selection, an approach complementary to measures of
negative selection such as amino acid conservation, may be
useful for identifying functionally important residues in
proteins, thereby improving algorithms for predicting the
functional effect of amino acid substitution.
The assumption of functional equivalence amongst homo-
logsisfundamental tosimpleaminoacidconservationanalysis
ingeneral: the functional constraints on a position that lead to
the observed conservation pattern are assumed to be constant
(or approximately so) in all of the related sequences. However,
there are many documented cases of missense substitutions
whose phenotypic effect is highly dependent on genetic
background. Among the most dramatic of these are human
disease mutations that are ﬁxed in the mouse genome with no
similar phenotypic effect [19], as well as alleles that have
different phenotypic effects in closely related mouse strains
[20]. In addition, the degree of functional constraint on a gene
is dependent on details of the population, such as effective
population size, and these effects are not accounted for in
simple conservation-based approaches.
It is therefore perhaps not surprising that both cases for
which PANTHER analysis failed to correctly predict the
functional consequence of amino acid substitution occur at
positions that have apparently played a key role in the
functional divergence of homologs, either paralogs (ABCA1
versus ABCA7) or even orthologs (human versus chimpanzee
ABCA1). The lack of strict conservation at these positions is
therefore not indicative of the lack of functional constraints;
it is instead due to divergence of protein function, either to
play a different role in the same organism (paralogs) or to
adjust to different selective pressures in a different genetic,
environmental, or population background (orthologs). Other
methodologies, such as those involving measures of positive
selection, will be required to recognize when an amino acid
change contributes to the divergence of function.
In summary, by combining a bioinformatics approach with
biochemical functional assays we have been able to deﬁne the
functional signiﬁcance of genetic variation in the ABCA1 gene
and to validate the use of PANTHER as a robust approach to
predicting allele function. These data have contributed to our
understanding of the functional effect of ABCA1 DNA
variants and, in addition, suggest that PANTHER may be a
useful tool in general for predicting the functional conse-
quence of DNA variation.
Materials and Methods
Datasets. We assembled a list of 30 missense mutations and ten
cSNPs reported in the ABCA1 gene [5]. In classifying a variant as a
‘‘SNP’’ or ‘‘mutation,’’ we have relied solely on their description in
the literature, with mutations being reported as variants that
segregate with TD in a kindred, and SNPs being more common
variants (.1% frequency) not associated with this disorder. We also
examined the group of ABCA1 variants recently reported to be
associated with low concentrations of HDL cholesterol in a
population based cohort [14].
Calculation of subPSEC scores. We used data from PANTHER [6]
to predict the functional consequence of each of the ABCA1 variants
described above. The ABCA1 protein was aligned to the highest-
scoring PANTHER (version 6.0, October 2005) HMMs: ABCA trans-
porter family and ABCA1 subfamily. subPSEC score calculations were
modiﬁed from previous descriptions [6,7] by using the equation
subPSEC ¼ 0.88ln(Pmin)   0.89ln(Pmax)   0.94ln(nic), where Pmin and
Pmax are the probabilities of the lower and higher probability amino
acids that are being evaluated, respectively, and nic (number of
independent counts) is the number of observations used to calculate
the probabilities (B. Lazareva, A. Kejariwal, and P. D. Thomas,
unpublished data). We discuss this method in more detail below.
Reported subPSEC scores for nearly all missense variants are
available online at the PANTHER database cSNP scoring page [21].
A small number of variants occur at positions that do not align to the
PANTHER library HMM (because these positions are not present in
most sequences that are members of the ABC transporter subfamily
A). To calculate subPSEC scores at these positions, we built an HMM
according to the method described [6], using human ABCA1 as the
seed sequence. Brieﬂy, this method forces each position in the seed
sequence to be modeled as a ‘‘match state’’ (so that a probability
vector will be calculated for every position), aligns all other sequences
in PTHR19229 to the seed, and then reestimates the probability
vectors using all of the aligned sequences. The alignment is not as
accurate overall as the PANTHER library alignment, but we veriﬁed
that it is accurate for the few positions that were not modeled by the
PANTHER library alignment.
The rationale and methodology for calculating subPSEC scores
have been reported previously [6,7], but we brieﬂy describe them
here, as well as describing recent improvements to the method (B.
Lazareva, A. Kejariwal, and P. D. Thomas, unpublished data). The goal
is to predict the functional effect of single amino acid substitutions in
proteins. From genomic and cDNA sequencing, there exists a great
deal of data about related protein sequences in extant organisms. To
the extent that these related sequences perform the same function,
they are under similar evolutionary constraints. Some of the random
mutations that occur during protein sequence evolution are func-
tionally neutral and can be ﬁxed in extant sequences, while most
mutations are selected against and will not appear in any of the
extant sequences. The effect of this negative selection is apparent in
the pattern of amino acids that appears in the equivalent positions in
related proteins. First order HMMs have proved to be an excellent
method for generating statistics on amino acid probabilities for
modeling protein families [22]. In these HMMs, each equivalent
position in related proteins is treated as a series of observations that
were ‘‘generated’’ by a ‘‘hidden’’ model represented as a Markov
chain. Each position is modeled as a vector (or ‘‘proﬁle’’)o f2 0
probabilities, one for each amino acid type. This proﬁle is derived
using a Bayesian method that weights prior knowledge (e.g., of
physicochemical similarities between amino acids) more heavily when
there are few observations. The method also weights different
sequences depending on their relatedness: for example, given a
human sequence, the yeast ortholog will be weighted more heavily in
deriving the probability vector than the chimp sequence because the
human and chimp sequences have had very little time to diverge
compared to human and yeast, and their mutually conserved
positions are due more to recent common ancestry than to negative
Figure 4. Graphic Representation of the Evolutionary Relationship
between Mouse, Human, and Chimpanzee ABCA1 Proteins
ABCA1 amino acid position 883 genotype is displayed under the species
name. An ‘‘X’’ represents the likely point in evolutionary history at which
the V883!M883 and M883!I883 mutation events occurred. The
M883!I883 mutation likely occurred since the divergence of the last
common ancestor between humans and chimpanzees, and the increased
activity of the I883 allele suggests that this may have been one of the
adaptive changes that occurred during the evolution of modern humans.
DOI: 10.1371/journal.pgen.0010083.g004
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pattern,’’ as a proﬁle can represent conservation of a single amino
acid (e.g., high probability for only methionine) or conservation of a
class of amino acids (e.g., high probabilities for only hydrophobic
amino acids). To score the substitution of amino acid b by amino acid
a, the subPSEC score uses the position-speciﬁc probabilities of a and b
in the proﬁle, according to the equation: subPSEC¼ln(Pa/Pb), so that
as Pa becomes smaller compared to Pb, subPSEC becomes increasingly
negative. Smaller subPSEC scores therefore predict a higher
probability of a deleterious functional effect.
The critical assumption in the subPSEC method is that the
evolutionary constraints are the same across the sequences used to
build the amino acid proﬁle. This is generally accepted to be
approximately true for orthologous sequences (sequences related by
a speciation event) and is the basis for complementation experi-
ments. Whether orthologs or paralogs, more closely related sequen-
ces are more likely to have similar functional constraints on their
evolution but, as described above, are less useful statistically because
of their recent common descent. We have therefore modiﬁed the
original subPSEC method to perform position-speciﬁc phylogenetic
sampling [6]. In this method, the set of sequences used to build the
amino acid proﬁle can be different for each position. If the position
is variable among orthologs, or conserved among orthologs but not
paralogs, then only orthologs are used to calculate the proﬁle
because a sequence divergence from other subfamilies of paralogous
proteins may be due to functional divergence. However, if the same
amino acid is conserved in all the orthologous sequences as well as in
the closest paralogous subfamily, we can add the paralogous
sequences to the set used to calculate the amino acid proﬁle. In
this case, we can assume that the evolutionary constraints are similar,
at least for that position. We can therefore use statistics from
paralogous proteins when the same amino acid is conserved at the
same position. This is done iteratively until a position is found either
to be divergent in a subtree or to be conserved across all paralogs in
the tree. We ﬁnd that the diversity of sequences over which a position
has been conserved (nic, or number of independent counts) is a useful
term to add to the subPSEC score, in addition to the probabilities of
the amino acids Pa and Pb. We performed log-linear logistic
regression to obtain the best discrimination between human
disease-causing variation and normal human variation (HGMD
versus dbSNP, as described [7]), obtaining estimates and standard
deviations for the coefﬁcients in the equation:
ln[Pdeleterious/(1   Pdeleterious)] ¼ CalnPa þ CblnPb þ Cnlnnic þ C, (1)
where a is the less probable amino acid and b is the more probable.
The coefﬁcients and standard deviations in their estimates were Ca¼
0.89 6 0.03, Cb¼ 0.88 6 0.03, Cn¼0.94 6 0.04, C¼3.00 6 0.13. For
this study, subPSEC was calculated as:
subPSEC ¼ 0.89lnPa   0.88lnPb þ 0.94lnnic, (2)
meaning that a cutoff of 3 corresponds to a 50% probability that the
score came from HGMD (presumably mostly deleterious) or dbSNP
(presumably mostly neutral). This allows us not only to calculate a
subPSEC score but also to convert that score into a probability of
deleterious functional effect Pdeleterious from Equation 1.
The distribution of random subPSEC scores for ABCA1 were
calculated as described previously [7]. Brieﬂy, all single nucleotide
substitutions in the coding sequence of ABCA1 were generated, and
those that led to amino acid substitutions were assigned subPSEC
scores. The distribution was obtained by weighting each amino acid
substitution according to the transition/transversion probabilities of
the corresponding nucleotide change.
Generation of stable cell lines. Polyclonal stable cell lines
expressing ABCA1 sequence variants were generated using the Flp-
in system (Invitrogen, Carlsbad, California, United States) as
previously described [23]. The generation and detailed biochemical
characterization of many of these cell lines are described elsewhere
(R. Singaraja, H. Visscher, E. R. James, G. Chimini, and M. R. Hayden,
unpublished data). Brieﬂy, the nucleotide mutations were incorpo-
rated into a human ABCA1 cDNA using PCR-based site-directed
mutatgenesis as previously described [24] (primer sequences and PCR
protocols are available on request) and cloned into the pcDNA5/FRT
expression vector (Invitrogen). All plasmids were completely
sequenced prior to transfection. Stable cell lines were generated by
cotransfecting human embryonic kidney 293 Flp-in cells (Invitrogen)
with the mutation-harboring plasmid and the pOG44 plasmid
(Invitrogen). Transfected cells were maintained in DMEM (GIBCO,
San Diego, California, United States) supplemented with 10% FCS, L-
glutamine, and penicillin and streptomycin. Hygromycin-resistant
colonies were selected for in 75 lg/ml Hygromyocin (Invitrogen),
trypsinized, and pooled to generate polyclonal cell lines.
Western blotting and RT-PCR. ABCA1 expression was deter-
mined by Western blotting, as previously described [25]. Brieﬂy, cells
were lysed in 20 mm HEPES, 5 mm KCl, 5 mm MgCl2, 0.5% (v/v)
Triton X-100, and complete protease inhibitor (Roche, Basel,
Switzerland), and protein concentration was determined by the
Lowry assay. Equivalent amounts of total protein were separated by
SDS-PAGE, transferred to PVDF membranes, and probed with anti-
ABCA1 [25] or anti-GAPDH (Chemicon, Temecula, California,
United States) antibodies.
RNA was isolated from cells using TriZOL reagent (Life Tech-
nologies, Carlsbad, California, United States), and 3 lg of total RNA
was reverse-transcribed using Superscript II (Life Technologies). RT-
PCR was performed using previously described primers and proto-
cols [26].
Cholesterol efﬂux. Efﬂux experiments were performed as pre-
viously described [23]. Brieﬂy, cells were loaded overnight with 1 lCi
of [
3H]cholesterol (Amersham Biosciences, Little Chalfont, United
Kingdom) in DMEM supplemented with 10% FCS, L-glutamine, and
penicillin and streptomycin. The following day, the medium was
removed and replaced with serum-free medium containing 0.2%
delipidated bovine serum albumin (Sigma, St. Louis, Missouri, United
States). After a 1-h incubation, 10 lg/ml human apoA-I (Athens
Research and Technology, Athens, Georgia, United States) was added.
After 4 h, the medium was removed and centrifuged, and cells were
lysed in 0.2% SDS. The amount of [
3H]cholesterol in the supernatant
and cells was determined by liquid scintillation spectroscopy.
Cholesterol efﬂux values are the mean of at least three separate
assays, each performed in triplicate, and are presented as mean 6 SD
of the difference between efﬂux in the presence and absence of apoA-
I. Each assay was performed together with wild-type ABCA1, and
values are expressed as percent of wild-type efﬂux. Signiﬁcance was
calculated using a one-way ANOVA test with a Newman-Keuls post-
test using GraphPad Prism 4 software (San Diego, California, United
States).
Supporting Information
Figure S1. Expression of the S1731C Allele in Polyclonal Stable Cell
Lines
ABCA1 protein (A) and mRNA (B) expression levels were determined
in an untransfected control cell line, and cells transfected with wild-
type ABCA1 or the S1731C variant. The cell line transfected with the
S1731C allele expressed low levels of protein (A), but normal levels of
mRNA (B), indicating that this variant impairs ABCA1 function by
inhibiting the generation of a stable protein.
Found at DOI: 10.1371/journal.pgen.0010083.sg001 (37 KB PDF).
Accession Numbers
The Online Mendelian Inheritance in Man (http://www.ncbi.nlm.nih.
gov/OMIM) accession number for TD is 2054000. The PANTHER
HMM accession numbers (http://www.pantherdb.org) are ABCA
transporter family (PTHR19229) and ABCA1 subfamily
(PTHR19229:SF34). The Entrez accession numbers (http://www.ncbi.
nlm.nih.gov/entrez) are ABCA1 (19), ABCA7 (10347), ABCA4 (24), and
ABCA2 (20).
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